What's different now?
We have a new administration in Washington along with a new Commissioner at the FDA. Expect a more aggressive approach to compliance regarding cosmetic regulations.
Cosmetic Labeling
We are challenged with these twin issues:
- Is the claim a drug claim or cosmetic claim?
- Are the claims substantiated?
Hard hitting claims continue to be critical to marketers, but expect more activity from the FDA - especially on the drug vs. cosmetic front.